TRL Triall

The project leverages blockchain and related technologies to make clinical trial processes tamper-resistant, and to enable secure and compliant connections between the many isolated systems and parties involved in clinical research.

Triall was founded back in 2018 and has since developed and commercialized its first product Verial eTMF, a blockchain-integrated document management application that enables clinical researchers to generate verifiable proofs of the existence, integrity, and authenticity of essential clinical trial documents.

Next to Verial eTMF, Triall will release several complementary, industry-validated applications that are all designed to support clinical trial professionals in their day-to-day operations. Moreover, the project is offering APIs that enable existing third-party clinical trial software providers to connect to Triall’s blockchain infrastructure. This provides them and their users a gateway to blockchain functionalities, and enables secure and compliant integrations with other applications in the Triall ecosystem.

Triall’s native TRL token enables access to ecosystem utilities, P2P compensation, governance, and community engagement.